Argeris N. Karabelas, Director, 10% Owner at INOTEK PHARMACEUTICALS CORP (ITEK), bought 667,392 shares at $6.00 ($3.6M) on 2015-02-23, disclosed to the SEC on 2015-02-25.
Open-market purchase of $3.6M ITEK by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 63,560 | $0 | 0.0% |
| 2 | $6.00 | 603,832 | $3.6M | 100.0% |
| Total | $5.43 avg | 667,392 | $3.6M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |